Crook Errol D
Wayne State University School of Medicine and John D. Dingell VA Medical Center, Detroit, Michigan, USA.
Am J Med Sci. 2002 Feb;323(2):78-84. doi: 10.1097/00000441-200202000-00004.
Diabetic nephropathy (DN) is the No. 1 cause of end-stage renal disease in the United States and is highly prevalent in African Americans. Almost all DN in African Americans is caused by type 2 diabetes. Glycemic control and control of blood pressure are essential to prolong renal survival and to protect against cardiovascular events. Among African Americans, diabetic nephropathy seems to affect women more than men, which may be related to increased rates of obesity and diabetes in African American women. In addition to gender, the development of albuminuria, family history, and possibly birth weight are factors that predict progression of renal disease in African Americans with DN. The impact of glycemic control, appropriate antihypertensives, and the optimal level of blood pressure control in African Americans with advanced DN require further study. This article will review the clinical characteristics, risk factors, predictors of disease progression, and treatment of diabetic nephropathy in African Americans.
糖尿病肾病(DN)是美国终末期肾病的首要病因,在非裔美国人中极为普遍。几乎所有非裔美国人的糖尿病肾病都是由2型糖尿病引起的。控制血糖和血压对于延长肾脏存活时间以及预防心血管事件至关重要。在非裔美国人中,糖尿病肾病似乎对女性的影响比对男性更大,这可能与非裔美国女性肥胖率和糖尿病发病率增加有关。除了性别之外,蛋白尿的出现、家族病史以及可能的出生体重都是预测非裔美国人糖尿病肾病患者肾病进展的因素。血糖控制、适当的抗高血压药物以及晚期糖尿病肾病非裔美国人的最佳血压控制水平的影响需要进一步研究。本文将综述非裔美国人糖尿病肾病的临床特征、危险因素、疾病进展的预测因素以及治疗方法。